Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Nucleic Acids Research|May 31, 2022
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agentsEnrico Ne, Raquel Crespo, Ray Izquierdo-Lara, et al.Msphere|May 28, 2021
Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 PatientsDebby van Riel, Carmen W E Embregts, Gregorius J Sips, et al.Journal of the International AIDS Society|July 13, 2023
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysisSarah E Stansfield, Jesse Heitner, Kate M Mitchell, et al.Science (New York, N.Y.)|July 4, 2009
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferretsVincent J Munster, Emmie de Wit, Judith M A van den Brand, et al.The Journal of General Virology|July 2, 2016
Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006Janko van Beek, Miranda de Graaf, Ming Xia, et al.Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.Scientific Reports|December 13, 2019
Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohortsAlan J Mueller-Breckenridge, Fernando Garcia-Alcalde, Steffen Wildum, et al.The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.Plos One|April 12, 2014
Patterns of transmitted HIV drug resistance in Europe vary by risk groupDineke Frentz, David van de Vijver, Ana Abecasis, et al.Pageof 4